Clinician-Patient Communication in Lung Cancer Care

Lung Cancer Clinical Trial

Official title:

Clinician-Patient Communication in Lung Cancer Care

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02732834
• Other study ID #: 16-001
• Status: Active, not recruiting
• Start date: January 2016
• Est. completion date: January 2025

Study information

• Verified date: February 2024
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to better understand communication between patients with lung cancer and their clinicians. The investigators are also interested in patient's perceptions of the quality of communication with his/her clinician and how these perceptions may impact patient outcomes. The clinician participating in this study and has given us permission to approach his/her eligible patients for study participation.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 294
• Est. completion date: January 2025
• Est. primary completion date: January 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with confirmed lung cancer diagnosis or mass suspicious of lung cancer as per clinician report and/or EMR

• Lung cancer diagnosis or suspicious mass as per clinician report/EMR within 0-6 months of consent or within no more than three visits to participating clinician

• Participating clinician approves his/her patient's participation in this study per clinician report.

• Former (at least 100 cigarettes in lifetime and quit more than 30 days prior to enrollment) or current smoker (lifetime smoker who reports cigarette smoking within the past 30 days) as per self report or EMR;

• English fluency (determined through EMR or clinician report), as we do not have the resources to translate the consultations from other languages or the surveys to other languages;

• Patients must be 18 years old or older

Clinician Inclusion Criteria:

• An MSK attending physician (radiologists, medical oncologists, and surgeons), Nurse Practitioner (NP), Physician Assistant (PA), Fellow, Resident or Clinical Nurse Specialist (CNS) or Clinical Nurse (RN) who is a member of the Thoracic Disease Management Team or Pulmonary Service currently treating thoracic patients at MSK as per self report

• Clinical has individual clinic consultations to discuss adult health assessment and/or smoking history with the target patient population: English-speaking, at least 18 years of age, has a suspicious lung mass or confirmed diagnosis, is a former/current smoker, has had no more than 3 visits with clinician or had diagnosis in past 6 months as per self-report.

Exclusion Criteria:

Clinician Exclusion Criteria

• N/A

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

Intervention

Behavioral:
• Questionnaire
patients will fill out a questionnaire about their perceived stigma, satisfaction with communication, and psychological distress.
• Patient Interview
Then they will participate in a brief in-person interview about their perceived stigma during the clinical consultation
• Audio recordings of clinical consultations

• Questionnaire
Patients will fill out a questionnaire about their perceived stigma and satisfaction with their clinician's communication.
• 2-hour empathic communication skills training
2-hour empathic communication skills training
• Standardized Patient Assessments
pre-training SPA, post-training SPA
• Training evaluation
Clinicians will complete an evaluation assessing the empathic communication training module.
• Patient recruitment
6 of the clinician's patients (3 pre-training, 3 post-training) will be recruited to complete brief surveys assessing clinician communication

Locations

Country	Name	City	State
United States	Memorial Sloan Kettering Basking Ridge (Consent and follow-up only)	Basking Ridge	New Jersey
United States	Memorial Sloan Kettering Commack (Consent and follow-up only)	Commack	New York
United States	Memorial Sloan Kettering Westchester (Consent and follow-up only)	Harrison	New York
United States	Memorial Sloan Kettering Monmouth (Consent and follow-up only)	Middletown	New Jersey
United States	Memorial Sloan Kettering Bergen (Consent and follow-up only)	Montvale	New Jersey
United States	Memorial Sloan Kettering Cancer Center	New York	New York
United States	Memorial Sloan Kettering Nassau (Consent and Follow-Up only)	Uniondale	New York

Sponsors (5)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center	Hamad Medical Corporation, University of Arizona, University of Florida, Weill Medical College of Cornell University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Part 1: Systematic coding of clinical encounters and the perceived stigma within the clinical consultation	interview along with patient-reported data from the post-consultation questionnaire will be used.	1 year
Primary	Part 1: All variables (stigma, satisfaction with communication, psychological distress)	will be measured via post-consultation questionnaires	1 year
Primary	Part 2: We will pilot test the effectiveness of the empathic communication skills training module	for clinicians: physicians, nurse practitioners, physician assistants, fellows, residents, clinical nurses, and clinical nurse specialists by using the communication skills training module	1 year
Secondary	# of patients referred to MSK's Tobacco Treatment Program (TTP)	will be determined via review of the medical record and/or Tobacco Treatment Program database	1 year

External Links

•   Memorial Sloan Kettering Cancer Center